We are live on ! Find out more
VanEck Associates

VanEck Associates Portfolio holdings

AUM $133B
1-Year Est. Return 72.99%
This Fund
S&P 500
This Quarter Est. Return
+6.76%
1 Year Est. Return
+72.99%
3 Year Est. Return
+157.94%
5 Year Est. Return
+206.35%
10 Year Est. Return
+770.56%
AUM
$70.4B
AUM Growth
+$4.22B
Cap. Flow
+$691M
Cap. Flow %
0.98%
Top 10 Hldgs %
28.49%
Holding
1,436
New
73
Increased
766
Reduced
481
Closed
68

Top Buys

Rank Stock Value
1
AMD icon
Advanced Micro Devices
AMD
+$479M
2
INTC icon
Intel
INTC
+$427M
3
WDAY icon
Workday
WDAY
+$223M
4
KVUE icon
Kenvue
KVUE
+$209M
5
ADBE icon
Adobe
ADBE
+$207M

Top Sells

Rank Stock Value
1
NVDA icon
NVIDIA
NVDA
+$760M
2
GOOGL icon
Alphabet (Google) Class A
GOOGL
+$245M
3
TER icon
Teradyne
TER
+$243M
4
WFC icon
Wells Fargo
WFC
+$228M
5
ECL icon
Ecolab
ECL
+$223M

Sector Composition

Rank Sector Weight
1 Technology 42.18%
2 Materials 24.65%
3 Healthcare 6.97%
4 Industrials 5.85%
5 Financials 4.67%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
RCM
1276
DELISTED
R1 RCM Inc. Common Stock
RCM
$65K ﹤0.01%
5,140
SPCE icon
1277
Virgin Galactic
SPCE
$329M
$61K ﹤0.01%
7,194
+96
+1% +$1.74K
HAIN icon
1278
Hain Celestial
HAIN
$44.4M
$60K ﹤0.01%
8,723
-878
-9% -$6.03K
BYND icon
1279
Beyond Meat
BYND
$286M
$57K ﹤0.01%
8,510
-1,379
-14% -$9.79K
OUST icon
1280
Ouster
OUST
$2.39B
$56K ﹤0.01%
+5,656
New +$57.2K
AZTA icon
1281
Azenta
AZTA
$1.33B
$55K ﹤0.01%
1,048
-83
-7% -$4.44K
SON icon
1282
Sonoco
SON
$5.62B
$55K ﹤0.01%
1,078
-107
-9% -$6.18K
FMX icon
1283
Fomento Económico Mexicano
FMX
$43.2B
$53K ﹤0.01%
496
GPRE icon
1284
Green Plains
GPRE
$1.21B
$53K ﹤0.01%
3,315
-51,999
-94% -$1M
NGVC icon
1285
Vitamin Cottage Natural Grocers
NGVC
$741M
$50K ﹤0.01%
2,368
+121
+5% +$2.3K
NTLA icon
1286
Intellia Therapeutics
NTLA
$1.55B
$49K ﹤0.01%
2,188
+85
+4% +$2.02K
PINC
1287
DELISTED
Premier
PINC
$49K ﹤0.01%
2,598
-372
-13% -$7.37K
SWX icon
1288
Southwest Gas
SWX
$6.54B
$49K ﹤0.01%
694
+64
+10% +$4.79K
RNW icon
1289
ReNew
RNW
$2.25B
$48K ﹤0.01%
7,765
-1,004,000
-99% -$6.03M
EQC
1290
DELISTED
Equity Commonwealth
EQC
$48K ﹤0.01%
2,471
-513
-17% -$9.78K
CVGW
1291
DELISTED
Calavo Growers
CVGW
$47K ﹤0.01%
2,062
+102
+5% +$2.67K
WEN icon
1292
Wendy's
WEN
$1.4B
$47K ﹤0.01%
2,760
-271
-9% -$4.92K
YUMC icon
1293
Yum China
YUMC
$15.9B
$46K ﹤0.01%
1,510
-47,887
-97% -$1.75M
FOLD
1294
DELISTED
Amicus Therapeutics
FOLD
$45K ﹤0.01%
4,564
MOMO
1295
Hello Group
MOMO
$886M
$45K ﹤0.01%
7,292
-948
-12% -$5.53K
GLOB icon
1296
Globant
GLOB
$1.57B
$44K ﹤0.01%
245
ITRI icon
1297
Itron
ITRI
$4.33B
$44K ﹤0.01%
444
+44
+11% +$4.43K
LMNR icon
1298
Limoneira
LMNR
$241M
$44K ﹤0.01%
2,117
+164
+8% +$3.3K
NFE icon
1299
New Fortress Energy
NFE
$94.6M
$44K ﹤0.01%
1,985
+180
+10% +$4.65K
OTLY
1300
Oatly Group
OTLY
$460M
$43K ﹤0.01%
2,270
-3,043
-57% -$64.7K

Similar funds

VanEck Associates's Q2 2024 Portfolio in Review

As of Q2 2024, VanEck Associates held 1,436 positions worth $70.4B, up 6.4% from $66.2B the previous quarter. Its ten largest holdings account for 28% of the portfolio.

VanEck Associates's Q2 2024 filing shows 73 new, 766 increased, 481 reduced and 68 closed positions. Its largest new stake was Bio-Rad Laboratories Class A: 659,222 shares worth $180M. The largest sale was NVIDIA, an estimated $760M.

By sector, the portfolio is most concentrated in Technology at 42% of assets, up from 37% a quarter earlier, followed by Materials and Healthcare.

  • VanEck Associates's largest Q2 2024 buy was Bio-Rad Laboratories Class A: 659,222 shares worth $180M.
  • VanEck Associates added most to Advanced Micro Devices in Q2 2024, an estimated $479M increase.
  • VanEck Associates's biggest Q2 2024 reduction was NVIDIA, cutting an estimated $760M.
  • VanEck Associates fully exited Wells Fargo in Q2 2024, selling an estimated $228M.
  • VanEck Associates's ten largest holdings make up 28% of its $70.4B portfolio in Q2 2024.
  • VanEck Associates opened 73 new positions and closed 68 in Q2 2024.
  • VanEck Associates's portfolio value rose 6.4% quarter-over-quarter to $70.4B.

Based on VanEck Associates's 13F filing for Q2 2024, filed 31 Jul 2024.